Largest pharmaceutical companies in the United States by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 44 pharmaceutical companies in the United States ranked by earnings, at CZK 596.3B, ahead of Eli Lilly (CZK 459.1B) and Merck & Co (CZK 406.1B). Figures as of 20 Nov 2026, 13:06 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 44
- First
- Johnson & JohnsonCZK 596.3B
- Median
- -CZK 1.1B
- Combined market value
- CZK 83.11T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | CZK 596.3B | CZK 14.31T | CZK 5,942.53 | 2.04% down | 31% up | ||
| 2 | Eli LillyLLY · Health Care | CZK 459.1B | CZK 26.77T | CZK 30,055.66 | 2.29% down | 28% up | ||
| 3 | Merck & CoMRK · Health Care | CZK 406.1B | CZK 7.28T | CZK 2,954.36 | 3.61% down | 36% up | ||
| 4 | PfizerPFE · Health Care | CZK 172.9B | CZK 3.49T | CZK 612.63 | 1.85% down | 10% up | ||
| 5 | Bristol-Myers SquibbBMY · Health Care | CZK 156.9B | CZK 2.65T | CZK 1,297.77 | 2.05% down | 26% up | ||
| 6 | Abbott LaboratoriesABT · Health Care | CZK 145.1B | CZK 4T | CZK 2,310.59 | 0.58% down | 19% down | ||
| 7 | Regeneron PharmaceuticalsREGN · Health Care | CZK 100.2B | CZK 2.12T | CZK 20,539.70 | 2.35% down | 22% up | ||
| 8 | AbbVieABBV · Health Care | CZK 94B | CZK 11.15T | CZK 6,307.35 | 0.86% down | 20% up | ||
| 9 | Vertex PharmaceuticalsVRTX · Health Care | CZK 87.9B | CZK 2.94T | CZK 11,582.08 | 2.94% down | 22% up | ||
| 10 | ZoetisZTS · Health Care | CZK 59.5B | CZK 730.2B | CZK 1,797.17 | 5.59% down | 34% down | ||
| 11 | United TherapeuticsUTHR · Health Care | CZK 29.7B | CZK 529.7B | CZK 12,437.18 | 3.16% down | 18% up | ||
| 12 | Royalty PharmaRPRX · Health Care | CZK 17.1B | CZK 866.2B | CZK 1,506.43 | 1.38% down | 74% up | ||
| 13 | PTC TherapeuticsPTCT · Health Care | CZK 15.2B | CZK 108.4B | CZK 1,297.44 | 3.16% down | 26% down | ||
| 14 | TG TherapeuticsTGTX · Health Care | CZK 9.9B | CZK 218.1B | CZK 1,443.26 | 1.88% down | 103% up | ||
| 15 | BioMarin PharmaceuticalBMRN · Health Care | CZK 7.8B | CZK 264.6B | CZK 1,366.29 | 0.02% down | 12% up | ||
| 16 | Alnylam PharmaceuticalsALNY · Health Care | CZK 7B | CZK 440.4B | CZK 3,288.26 | 1.06% down | 66% down | ||
| 17 | Ligand PharmaceuticalsLGND · Health Care | CZK 2.8B | CZK 127.7B | CZK 6,382.98 | 3.94% down | 44% up | ||
| 18 | Corcept TherapeuticsCORT · Health Care | CZK 2.2B | CZK 158.2B | CZK 1,445.48 | 4.15% down | 16% down | ||
| 19 | Amneal PharmaceuticalsAMRX · Health Care | CZK 1.6B | CZK 165.8B | CZK 475.82 | 2.24% down | 79% up | ||
| 20 | Arrowhead PharmaceuticalsARWR · Health Care | -CZK 36.3M | CZK 137.3B | CZK 970.99 | 1.25% up | 8% up | ||
| 21 | Mirum PharmaceuticalsMIRM · Health Care | -CZK 519.7M | CZK 138.7B | CZK 2,124.62 | 3.27% up | 35% up | ||
| 22 | Travere TherapeuticsTVTX · Health Care | -CZK 568.3M | CZK 103.1B | CZK 1,074.43 | 3.86% down | 39% up | ||
| 23 | VeradermicsMANE · Health Care | -CZK 1.6B | CZK 116.8B | CZK 2,767.06 | 0.38% down | 230% up | ||
| 24 | Belite BioBLTE · Health Care | -CZK 1.7B | CZK 136.4B | CZK 3,359.44 | 3.33% down | 25% up | ||
| 25 | Oruka TherapeuticsORKA · Health Care | -CZK 2.3B | CZK 147.2B | CZK 2,170.44 | 1.91% up | 233% up | ||
| 26 | ErascaERAS · Health Care | -CZK 2.8B | CZK 111B | CZK 316.32 | 3.34% up | 387% up | ||
| 27 | Protagonist TherapeuticsPTGX · Health Care | -CZK 2.9B | CZK 180.1B | CZK 2,758.82 | 2.47% down | 45% up | ||
| 28 | Spyre TherapeuticsSYRE · Health Care | -CZK 3.5B | CZK 206.3B | CZK 2,171.78 | 3.77% down | 302% up | ||
| 29 | Dianthus TherapeuticsDNTH · Health Care | -CZK 3.6B | CZK 106.3B | CZK 1,887.04 | 1.01% up | 105% up | ||
| 30 | Edgewise TherapeuticsEWTX · Health Care | -CZK 3.7B | CZK 100.3B | CZK 915.83 | 0.48% down | 82% up | ||
| 31 | Axsome TherapeuticsAXSM · Health Care | -CZK 4.1B | CZK 158.8B | CZK 3,018.20 | 1.25% up | 9% down | ||
| 32 | Definium TherapeuticsDFTX · Health Care | -CZK 4.1B | CZK 89.8B | CZK 655.78 | 1.24% up | 176% up | ||
| 33 | Rhythm PharmaceuticalsRYTM · Health Care | -CZK 4.4B | CZK 180.1B | CZK 2,598.22 | 1.88% down | 15% up | ||
| 34 | Elanco Animal HealthELAN · Health Care | -CZK 5.2B | CZK 292.3B | CZK 584.82 | 1.54% down | 18% up | ||
| 35 | Madrigal PharmaceuticalsMDGL · Health Care | -CZK 6.4B | CZK 205B | CZK 8,825.48 | 0.34% down | 28% down | ||
| 36 | Legend BiotechLEGN · Health Care | -CZK 6.6B | CZK 69.5B | CZK 358.14 | 0.92% down | 43% down | ||
| 37 | Praxis Precision MedicinesPRAX · Health Care | -CZK 6.7B | CZK 193.3B | CZK 6,915.97 | 1.87% up | 83% up | ||
| 38 | Cogent BiosciencesCOGT · Health Care | -CZK 7.3B | CZK 107.4B | CZK 617.08 | 0.25% down | 25% down | ||
| 39 | Ionis PharmaceuticalsIONS · Health Care | -CZK 8.5B | CZK 100.8B | CZK 605.51 | 0.62% down | 64% down | ||
| 40 | BridgeBio PharmaBBIO · Health Care | -CZK 16.3B | CZK 338.8B | CZK 1,739.11 | 0.22% up | 15% up | ||
| 41 | CytokineticsCYTK · Health Care | -CZK 17.5B | CZK 159.5B | CZK 1,144.73 | 0.27% up | 21% down | ||
| 42 | Summit TherapeuticsSMMT · Health Care | -CZK 24B | CZK 188B | CZK 235.13 | 0.67% up | 35% down | ||
| 43 | InsmedINSM · Health Care | -CZK 28.4B | CZK 705B | CZK 3,213.51 | 20.58% up | 27% down | ||
| 44 | ViatrisVTRS · Health Care | -CZK 78.2B | CZK 507B | CZK 442.23 | 1.97% down | 90% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 22.2450 CZK).
Questions and answers
Which pharmaceutical companies in the United States rank first by earnings?
Johnson & Johnson (CZK 596.3B), Eli Lilly (CZK 459.1B) and Merck & Co (CZK 406.1B) are the top three of the 44 pharmaceutical companies in the United States ranked by earnings as of 20 Nov 2026, 13:06 UTC.
How many pharmaceutical companies in the United States are in this ranking?
44 are ranked by earnings.
What are these pharmaceutical companies in the United States worth together?
The 44 pharmaceutical companies in the United States ranked by earnings have a combined market value of CZK 83.11T as of 20 Nov 2026, 13:06 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies in the United States by earnings”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.